A new scientific discovery is offering a promising breakthrough for people struggling with hay fever and asthma triggered by pollen. Scientists have found a way to stop allergic reactions caused by ...

Dupilumab in patients with diffuse type 2 CRSwNP had beneficial changes in nasal passage microbiota but did not alter gastrointestinal microbiota.